(Q24194973)

1

0 references

Leila Ferguson

2

0 references

Efstratios Vakirlis

3

0 references

Reiji Kojima

4

0 references

Amanda Roberts

Cochrane Database of Systematic Reviews

5

0 references

publication date

30 July 2014

0 references

published in

0 references

cites work

Urinary leukotriene levels are increased during exacerbation of atopic eczema/dermatitis syndrome. Relation to clinical status

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Topical pimecrolimus for eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

A systematic review of the safety of topical therapies for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Burden of allergic disease in the UK: secondary analyses of national databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Short-course montelukast for intermittent asthma in children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Relieving the pruritus of atopic dermatitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Systemic therapy of atopic dermatitis in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Epidemiology of atopic dermatitis and atopic march in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011224

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD011224

0 references

Fatcat ID

release_x4jmrqf3sjgajexepqtd433sg4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x4jmrqf3sjgajexepqtd433sg4